Activity of Ethics Committees in Europe on issues related to clinical trials in paediatrics: Results of a survey

A. Altavilla, C. Giaquinto, D. Giocanti, C. Manfredi, J. Aboulker, F. Bartoloni, E. Cattani, M. L. Giudice, M. J. M. Peña, R. Nagler, C. Peterson, O. Vajnerová, F. Bonifazi, A. Ceci
{"title":"Activity of Ethics Committees in Europe on issues related to clinical trials in paediatrics: Results of a survey","authors":"A. Altavilla, C. Giaquinto, D. Giocanti, C. Manfredi, J. Aboulker, F. Bartoloni, E. Cattani, M. L. Giudice, M. J. M. Peña, R. Nagler, C. Peterson, O. Vajnerová, F. Bonifazi, A. Ceci","doi":"10.3233/PPL-2009-0208","DOIUrl":null,"url":null,"abstract":"The rights and well-being of children involved in clinical research in Europe should be assured by the respect of ethical considerations and legal rules. Specific provisions are included in the Directive 2001/20/EC (CT-Dir) aimed at providing a homogeneous ethical and legal context to perform clinical trials in Europe. The TEDDY Network of Excellence carried out a “Survey on the ethical and legal frameworks existing in Europe for paediatric clinical trials” to examine the measures enforced by Member States to implement the CT-Dir and other relevant ethical norms. The results showed that many differences exist in the protection of children enrolled in clinical trials. Such differences are especially due to a non-coordinated implementation of the Directive’s Article 4 and a lack of public awareness on ethical issues in this field. The recently approved ‘Ethical considerations for clinical trials on medicinal products conducted with the paediatric population’ should speed up the implementation of an ‘ad hoc set of ethical rules’ and increase the level of minors’ protection. Nevertheless, in lack of ‘binding rules’, a coordination at European level is still needed. Public initiatives aiming at promoting in-depth debates have to be supported in order to encourage this process of coordination.","PeriodicalId":348240,"journal":{"name":"Pharmaceuticals, policy and law","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceuticals, policy and law","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/PPL-2009-0208","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

The rights and well-being of children involved in clinical research in Europe should be assured by the respect of ethical considerations and legal rules. Specific provisions are included in the Directive 2001/20/EC (CT-Dir) aimed at providing a homogeneous ethical and legal context to perform clinical trials in Europe. The TEDDY Network of Excellence carried out a “Survey on the ethical and legal frameworks existing in Europe for paediatric clinical trials” to examine the measures enforced by Member States to implement the CT-Dir and other relevant ethical norms. The results showed that many differences exist in the protection of children enrolled in clinical trials. Such differences are especially due to a non-coordinated implementation of the Directive’s Article 4 and a lack of public awareness on ethical issues in this field. The recently approved ‘Ethical considerations for clinical trials on medicinal products conducted with the paediatric population’ should speed up the implementation of an ‘ad hoc set of ethical rules’ and increase the level of minors’ protection. Nevertheless, in lack of ‘binding rules’, a coordination at European level is still needed. Public initiatives aiming at promoting in-depth debates have to be supported in order to encourage this process of coordination.
欧洲伦理委员会在儿科临床试验相关问题上的活动:一项调查结果
在欧洲,参与临床研究的儿童的权利和福祉应通过尊重伦理考虑和法律规则得到保证。指令2001/20/EC (CT-Dir)中包含了具体规定,旨在为在欧洲进行临床试验提供统一的伦理和法律环境。TEDDY卓越网络开展了一项“关于欧洲现有儿科临床试验伦理和法律框架的调查”,以审查成员国为实施CT-Dir和其他相关伦理规范而采取的措施。结果表明,在保护参加临床试验的儿童方面存在许多差异。这种差异主要是由于指令第4条的执行不协调以及公众对该领域道德问题缺乏认识。最近批准的《针对儿科人群进行药品临床试验的伦理考虑》应当加快“一套特别伦理规则”的实施,并提高对未成年人的保护水平。然而,由于缺乏“约束性规则”,欧洲层面的协调仍然是必要的。必须支持旨在促进深入辩论的公共倡议,以鼓励这一协调进程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信